PeterAllenLinfootMDPHD

PubMed

• Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets
  Jean-Marc Schwarz, Peter A. Linfoot, Doris Dare, Karmen Aghajanian> ;The American Journal of Clinical Nutrition. 2003 Jan 1
• Effect of dietary energy restriction on glucose production and substrate utilization in type 2 diabetes.
  Mark P. Christiansen, Peter A. Linfoot, Richard A. Neese, Marc K. Hellerstein> ;Diabetes. 2000 Oct 1
• Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study.
  Marc K. Hellerstein, Richard A. Neese, Peter A. Linfoot, Mark P. Christiansen, Scott Turner, A Letscher> ;Journal of Clinical Investigation. 1997 Sep 1
• Production of stable phenotypes from 9L rat brain tumor multicellular spheroids treated with 1,3-bis(2-chloroethyl)-1-nitrosourea.
  Mary Helen Barcellos-Hoff, Peter A. Linfoot, Laurence J. Marton, Dennis F. Deen> ;International Journal of Cancer. 1992 Sep 30
• Cell-cycle, phase-specific cell killing by carmustine in sensitive and resistant cells.
  Peter A. Linfoot, Mary Helen Barcellos-Hoff, Brent Tp, L. J. Marton, Dennis F. Deen> ;NCI monographs : a publication of the National Cancer Institute. 1988 Jan 1
• Effect of cell cycle position on the survival of 9L cells treated with nitrosoureas that alkylate, cross-link, and carbamoylate.
  Peter A. Linfoot, Joe W. Gray, P. N. Dean, Laurence J. Marton, Dennis F. Deen> ;Cancer Research. 1986 May 1
• Sources of plasma glucose and liver glycogen in fasted ob/ob mice.
  Turner, S. M., Linfoot, P. A., Neese, R. A., Hellerstein, M. K.> ;Acta Diabetol. 2005 Dec
• Join now to see all